Contact Us

About

Elevating human life through scientific innovation.

Company Management Directions

Science

Developing gene therapies to reduce patient suffering.

Why AAV Gene Therapy Platform Technology Grants & Awards Publication

Pipeline

Explore our gene therapy pipeline.

Overview NG101 EG103 EG201

Investors & Newsroom

Stay updated on our latest research and company news.

Notices News Resources
Community

Community

Community

Publication

[Poster - Retina Society 2025] Six-Month First-in-Human Safety and Efficacy Data of Subretinal NG101 – A Novel Low-Dose AAV Gene Therapy for Wet AMD